216 related articles for article (PubMed ID: 37478222)
21. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients.
Wang Z; Zhang N; Lv J; Ma C; Gu J; Du Y; Qiu Y; Zhang Z; Li M; Jiang Y; Zhao J; Du H; Zhang Z; Lu W; Zhang Y
Biomed Res Int; 2020; 2020():4037639. PubMed ID: 33163533
[TBL] [Abstract][Full Text] [Related]
22. Construction and validation of an angiogenesis-related scoring model to predict prognosis, tumor immune microenvironment and therapeutic response in hepatocellular carcinoma.
Tang B; Zhang X; Yang X; Wang W; Li R; Liu Y
Front Immunol; 2022; 13():1013248. PubMed ID: 36466855
[TBL] [Abstract][Full Text] [Related]
23. A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma.
Chen W; Yang Z; Chen Y
Dis Markers; 2022; 2022():3594901. PubMed ID: 36105252
[TBL] [Abstract][Full Text] [Related]
24. DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma.
Lu Y; Wang S; Chi T; Zhao Y; Guo H; Wang H; Feng L
Sci Rep; 2023 Nov; 13(1):18978. PubMed ID: 37923899
[TBL] [Abstract][Full Text] [Related]
25. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
Zhen Z; Shen Z; Hu Y; Sun P
Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
[TBL] [Abstract][Full Text] [Related]
26. Identification of anoikis related subtypes and construction of prognostic model in hepatocellular carcinoma.
Fang W; Chen Z
Cell Mol Biol (Noisy-le-grand); 2023 Sep; 69(9):219-228. PubMed ID: 37807308
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
28. Exploration and validation of the prognostic value of RNA-binding proteins in hepatocellular carcinoma.
Wang J; Han K; Li Y; Zhang C; Cui WH; Zhu LH; Luo T; Bian CJ
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8945-8958. PubMed ID: 36524514
[TBL] [Abstract][Full Text] [Related]
29. Construction of a gene signature associated with anoikis to evaluate the prognosis and immune infiltration in patients with colorectal cancer.
Wen H; Ni X; Qian S; Abdul S; Lv H; Chen Y
Transl Cancer Res; 2024 Apr; 13(4):1904-1923. PubMed ID: 38737694
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
Wang Y; Song F; Zhang X; Yang C
Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
[TBL] [Abstract][Full Text] [Related]
31. Correlation of endoplasmic reticulum stress patterns with the immune microenvironment in hepatocellular carcinoma: a prognostic signature analysis.
Zhan K; Yang X; Li S; Bai Y
Front Immunol; 2023; 14():1270774. PubMed ID: 38143739
[TBL] [Abstract][Full Text] [Related]
32. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.
Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R
Front Genet; 2022; 13():907331. PubMed ID: 35938001
[No Abstract] [Full Text] [Related]
33. A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma.
Chen J; Wang H; Zhou L; Liu Z; Chen H; Tan X
Cancer Med; 2022 Dec; 11(24):5079-5096. PubMed ID: 35560794
[TBL] [Abstract][Full Text] [Related]
34. Prognostic model for hepatocellular carcinoma based on anoikis-related genes: immune landscape analysis and prediction of drug sensitivity.
Zhang D; Liu S; Wu Q; Ma Y; Zhou S; Liu Z; Sun W; Lu Z
Front Med (Lausanne); 2023; 10():1232814. PubMed ID: 37502362
[TBL] [Abstract][Full Text] [Related]
35. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
36. A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma.
Chen Z; Liu X; Zhu Z; Chen J; Wang C; Chen X; Zhu S; Zhang A
Front Genet; 2022; 13():1039465. PubMed ID: 36338978
[No Abstract] [Full Text] [Related]
37. A stemness-based eleven-gene signature correlates with the clinical outcome of hepatocellular carcinoma.
Hong L; Zhou Y; Xie X; Wu W; Shi C; Lin H; Shi Z
BMC Cancer; 2021 Jun; 21(1):716. PubMed ID: 34147074
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of an autophagy-related prognostic model for predicting survival based on TCGA and ICGC database in hepatocellular carcinoma patients.
An LN; Du L; Wang LL; Chen J; Wang XR; Duan JP
J Gastrointest Oncol; 2022 Dec; 13(6):3154-3168. PubMed ID: 36636069
[TBL] [Abstract][Full Text] [Related]
39. Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.
Liu Z; Wang J; Li S; Li L; Li L; Li D; Guo H; Gao D; Liu S; Ruan C; Dang X
Front Immunol; 2022; 13():1076045. PubMed ID: 36591279
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of an eight-gene signature based predictive model to evaluate the prognosis of hepatocellular carcinoma patients: a bioinformatic study.
Zhang J; Fu X; Zhang N; Wang W; Liu H; Jia Y; Nie Y
Ann Transl Med; 2022 May; 10(9):524. PubMed ID: 35928748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
